Avid selects MilliporeSigma to meet single-use trend

By Flora Southey contact

- Last updated on GMT

Avid Bioservices has installed two MilliporeSigma Mobius 2,000L single-use bioreactors at its facility in Tustin, California, US.

Avid Bioservices – a subsidiary of Peregrine Pharmaceuticals – said it reviewed several suppliers before choosing MilliporeSigma’s technology.

“Avid ran a competitive process in considering which single-use bioreactors to install in our Myford​ [Myford Road, Tustin] facility,” ​said president Roger Lias.

“While we carefully reviewed a number of single-use bioreactor options, we chose the MilliporeSigma Mobius 2,000L single-use bioreactor system because it offers technical and ease of use advantages over competing single-use systems,” ​he told us. 

The contract development and manufacturing organisation (CDMO) did not disclose the purchase price.

New business

Avid said it opted for single-use bioreactors in response to growing demand for larger scale, disposable technology.

“This enhancement of our capabilities is just the latest step in our ongoing efforts to expand and diversify our customer base,” ​said Lias.

The firm told us a percentage of bioreactor capacity had already been allocated to customers.

“With not all capacity currently accounted for we are able to offer prospective new clients a unique short-term opportunity to obtain capacity in a cutting-edge commercial facility,” ​Lias told us.

Avid said it has room to house one additional 2,000L bioreactor at its Myford Road facility.

A move to single-use?

Lias said single-use technology is a growing trend in the biopharmaceutical industry.

“We believe that there is a clear movement within the industry toward single-use, fully disposable manufacturing” ​he told us.

Disposable bioreactors improves turnaround times, reduces product cross-contamination risk and decreases capital costs, he said.

“Single-use manufacturing technology helps accelerate moving molecules to market, improves productivity and ensures supply continuity,” ​he added.

Related news

Show more

Related products

show more

Cultivation of 3D Cell Aggregates in Perfusion

Cultivation of 3D Cell Aggregates in Perfusion

Eppendorf for Bioprocess – Solutions that grow with you | 17-Sep-2018 | Application Note

3D cell aggregates are of great interest for applications like disease modeling and manufacturing of stem cell-based products. Read more about the cultivation...

Downstream Purification of Large Biomolecules

Downstream Purification of Large Biomolecules

Bio-Rad Laboratories | 17-Sep-2018 | Research Study

Our newest strong anion exchange resin provides both high binding capacity and
high recovery, even at high flow rates. A rigid bead complete with...


Inline concentration improves process economics

Pall Biotech | 15-Jun-2018 | Case Study

Would you like to enhance your downstream process, increase production capacity and reduce costs? This case study application note demonstrates how implementing...

Featured eBook: Complex Protein Production

Featured eBook: Complex Protein Production

Catalent Pharma Solutions | 06-Mar-2018 | Technical / White Paper

Download the eBook written by Catalent experts to learn about innovative products and techniques for scale-up of complex biologics, get optimal cell culture...

Related suppliers

Follow us


View more